Condensed Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net Sales		$ 2,615,807	$ 2,476,134	$ 7,680,733	$ 8,813,128
Cost of Sales		1,436,552	1,411,573	4,290,351	5,639,925
Gross Profit		1,179,255	1,064,561	3,390,382	3,173,203
Operating Expenses
Selling expenses		415,903	592,089	1,380,585	1,871,696
General and administrative expenses		1,948,988	1,523,409	4,430,790	3,904,147
Research and development		1,221,231		1,971,929	10,144
Total Operating Expenses		3,586,122	2,115,498	7,783,304	5,785,987
Loss From Operations		(2,406,867)	(1,050,937)	(4,392,922)	(2,612,784)
Other Expenses
Non-operating income		201	316	2,944	18,208
Foreign exchange transaction income (loss)		(74)	(43,738)	70,575	(177,399)
Interest expense, net		(8,792)	(1,358)	(21,360)	(4,589)
Financial expense		(50,321)	(45,541)	(146,459)	(123,190)
Total Other Expenses, Net		(58,986)	(90,321)	(94,300)	(286,970)
Loss Before Income Taxes		(2,465,853)	(1,141,258)	(4,487,222)	(2,899,754)
Income Tax Expense		(211)	(147,371)	(5,087)	(149,771)
Net Loss		(2,466,064)	(1,288,629)	(4,492,309)	(3,049,525)
Other Comprehensive Loss
Foreign currency translation		(63,404)	194,710	(146,004)	95,420
Net Loss and Comprehensive Loss		$ (2,529,468)	$ (1,093,919)	$ (4,638,313)	$ (2,954,105)
Weighted average shares outstanding - Basic	[1]	3,446,032	1,547,423	2,743,021	1,484,358
Weighted average shares outstanding - Diluted	[1]	3,446,032	1,547,423	2,743,021	1,484,358
Net loss per share of common stock
Basic		$ (0.72)	$ (0.83)	$ (1.64)	$ (2.05)
Diluted		$ (0.72)	$ (0.83)	$ (1.64)	$ (2.05)

[1] Including 0 shares that were granted and vested but not yet issued for the nine and three months ended September 30, 2024 and 2023, respectively.